Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...

Mucinex knocked Vicks off the top spot for monthly TV ad impressions as pharma brands generated significant coverage from ...

Budweiser broke out the Clydesdales to win USA TODAY Ad Meter 2025, the ninth time the brand has claimed the prize as the Super Bowl's best commercial. The beer brand brought back the beloved ...

The ad cost an estimated $2 million for the Secret Service to produce, according to two sources familiar with the project — a hefty price tag that comes amid massive budget cuts and layoffs at ...

For the ninth time, Budweiser emerged as the winner of USA TODAY’s Ad Meter contest as viewers voted “First Delivery,” a tale of a Clydesdale foal proving its mettle, the No. 1 commercial in ...

Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi and Regeneron's Dupixent (dupilumab) for COPD - as has China's National ...

These top 10 best print ads should inspire anyone developing their print campaign to think boldly and take risks. Get more inspiration on the ID Blog. With digital channels like social media and ...

Apple Search Ads platforms provide a targeted way for app owners and marketers to reach potential users at the moment they’re ready to download. Unlike ads on Facebook, Google, or Instagram, which ...

Celldex has a strong cash position with a runway of 13-14 quarters, bolstered by a $424 million secondary offering in March 2024. Learn more on CLDX stock here.

Acceptance follows resolution of third-party fill/finish manufacturing issues FDA decision expected by July 10, 2025 TARRYTOWN, N.Y., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.